The combination of circulating Ang1 and Tie2 levels predicts progression-free survival advantage in bevacizumab-treated patients with ovarian cancer

Alison Backen, AG Renehan, Andrew Clamp, Carlo Berzuini, Cong Zhou, A Oza, S Bannoo, SJ Scherer, RE Banks, Caroline Dive, Gordon Jayson

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'The combination of circulating Ang1 and Tie2 levels predicts progression-free survival advantage in bevacizumab-treated patients with ovarian cancer'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Food Science